Huntington National Bank Biotechnology

Huntington National Bank

$13.5 Billion
Q3 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
HRTX Heron Therapeutics, Inc.	$127M	$2,000 0.0% of portfolio	1,209	Q3 2024 Added 65.39%
ALLO Allogene Therapeutics, Inc.	$318M	$1,000 0.0% of portfolio	449	Q3 2024 Reduced 35.3%
CORT Corcept Therapeutics Inc	$6.16B	$1,000 0.0% of portfolio	29	Q2 2024 Added 163.64%
NTLA Intellia Therapeutics, Inc.	$1.09B	$1,000 0.0% of portfolio	70	Q2 2024 Reduced 51.39%
JANX Janux Therapeutics, Inc.	$2.1B	$1,000 0.0% of portfolio	41	Q3 2024 Added 95.24%
SRNE Sorrento Therapeutics, Inc.	$148M	$1,000 0.0% of portfolio	5,001	Q4 2023 Reduced 66.66%
TSVT 2seventy Bio, Inc.	$137M	$1,000 0.0% of portfolio	233	Q3 2024 New
TBPH Theravance Biopharma, Inc.	$632M	$1,000 0.0% of portfolio	138	Q3 2024 Added 56.82%
ADPT Adaptive Biotechnologies Corp	$670M	$0 0.0% of portfolio	1	Q4 2023 Reduced 99.81%
AIM Aim Immuno Tech Inc.	$10.1M	$0 0.0% of portfolio	57	Q4 2019 New
ALBO Albireo Pharma, Inc.	$0	$0 0.0% of portfolio	1	Q1 2023 Reduced 99.88%
ALT Altimmune, Inc.	$426M	$0 0.0% of portfolio	2	Q3 2023 Reduced 99.89%
ARDX Ardelyx, Inc.	$796M	$0 0.0% of portfolio	50	Q3 2024 New
RCUS Arcus Biosciences, Inc.	$1.06B	$0 0.0% of portfolio	13	Q3 2024 Added 44.44%
ARWR Arrowhead Pharmaceuticals, Inc.	$1.96B	$0 0.0% of portfolio	21	Q3 2024 Added 75.0%
AUPH Aurinia Pharmaceuticals Inc.	$1.26B	$0 0.0% of portfolio	2	Q2 2023 Reduced 99.68%
AUTL Autolus Therapeutics PLC	$267M	$0 0.0% of portfolio	1	Q2 2023 Reduced 99.93%
BGNE Bei Gene, Ltd.	$19.8B	$0 0.0% of portfolio	1	Q1 2024 Reduced 75.0%
CVM Cel Sci Corp	$26M	$0 0.0% of portfolio	500	Q2 2023 New
APOP Cellect Biotechnology Ltd.	$51.5M	$0 0.0% of portfolio	-	Q3 2021 New
CDXS Codexis, Inc.	$302M	$0 0.0% of portfolio	2	Q3 2023 Reduced 99.88%
CHRS Coherus Bio Sciences, Inc.	$84.7M	$0 0.0% of portfolio	1	Q4 2021 New
GBIO Generation Bio Co.	$80.8M	$0 0.0% of portfolio	1	Q3 2021 Reduced 99.52%
GBT Global Blood Therapeutics, Inc.	$4.62B	$0 0.0% of portfolio	1	Q4 2022 Reduced 99.55%
HTBX Heat Biologics, Inc.	$60.5M	$0 0.0% of portfolio	1	Q4 2020 Reduced 90.91%
IMGN Immuno Gen, Inc.	$0	$0 0.0% of portfolio	1	Q1 2024 Reduced 98.31%
INVA Innoviva, Inc.	$1.33B	$0 0.0% of portfolio	10	Q2 2024 New
MRVI Maravai Lifesciences Holdings, Inc.	$687M	$0 0.0% of portfolio	52	Q1 2024 Reduced 78.06%
NKTR Nektar Therapeutics	$197M	$0 0.0% of portfolio	1	Q1 2020 Reduced 99.88%
OMGA Omega Therapeutics, Inc.	$37.8M	$0 0.0% of portfolio	1	Q4 2023 New
ORMP Oramed Pharmaceuticals Inc.	$90.9M	$0 0.0% of portfolio	2	Q3 2024 Reduced 99.96%
OYST Oyster Point Pharma, Inc.	$0	$0 0.0% of portfolio	1	Q1 2023 Reduced 99.89%
PVCT Provectus Biopharmaceuticals, Inc.	$50.3M	$0 0.0% of portfolio	1	Q2 2019 New
RGNX Regenxbio Inc.	$415M	$0 0.0% of portfolio	64	Q1 2024 New
RIGL Rigel Pharmaceuticals Inc	$4.5B	$0 0.0% of portfolio	1	Q2 2024 Reduced 99.81%
SAGE Sage Therapeutics, Inc.	$307M	$0 0.0% of portfolio	1	Q2 2024 Reduced 98.97%
TARS Tarsus Pharmaceuticals, Inc.	$1.29B	$0 0.0% of portfolio	1	Q1 2024 Reduced 99.93%
VERU Veru Inc.	$54.5M	$0 0.0% of portfolio	1	Q4 2021 New
VIR Vir Biotechnology, Inc.	$944M	$0 0.0% of portfolio	40	Q3 2024 Added 90.48%
MYOV Myovant Sciences Ltd.	$0	$0 0.0% of portfolio	1	Q4 2021 New
ROIV Roivant Sciences Ltd.	$8.83B	$0 0.0% of portfolio	42	Q3 2024 Added 2.44%
IMTX Immatics N.V.	$579M	$0 0.0% of portfolio	1	Q3 2024 Reduced 99.86%
QURE Uni Qure N.V.	$270M	$0 0.0% of portfolio	2	Q1 2022 Reduced 99.28%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Huntington National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Huntington National Bank with notifications on news.